A Clinical Trial of Two Adjuvant Chemotherapy Regimens for Postoperative Gastric Cancer
Status:
Not yet recruiting
Trial end date:
2024-06-01
Target enrollment:
Participant gender:
Summary
This study was a prospective, randomized, controlled phase III clinical study to evaluate the
efficacy and safety of docetaxel plus oxaliplatin and capecitabine versus oxaliplatin plus
capecitabine in the treatment of gastric or gastroesophageal junction adenocarcinoma with
postoperative pathological stage IIIB and IIIC.